Related Experiment Video
Updated: Jan 14, 2026

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
Published on: October 6, 2022
HIV and Cardiovascular Disease Burden in Young Adults (18-25 years): A Review of Current Evidence
Edith D Majonga1,2, Anoop S V Shah3
1Biomedical Research and Training Institute, Harare, Zimbabwe. Edith.Majonga@lshtm.ac.uk.
Insights
Cardiovascular disease (CVD) in youth with HIV is driven by non-atherosclerotic mechanisms, not just traditional atherosclerosis. More research is needed to understand and reduce this burden.
Area of Science:
- Cardiology
- Infectious Diseases
- Public Health
Background:
- Young people living with HIV (PLWH) face a growing burden of cardiovascular disease (CVD).
- Traditional risk factors for CVD may not fully explain the pathology in this population.
- Understanding HIV-associated CVD mechanisms in youth is critical for effective management.
Purpose of the Study:
- To synthesize current evidence on the cardiovascular disease burden in young people living with HIV.
- To explore myocardial and vascular pathology in HIV-associated CVD among youth.
- To evaluate advanced imaging techniques and identify knowledge gaps in HIV-associated CVD mechanisms.
Main Methods:
- Systematic review of current scientific literature.
- Analysis of myocardial and vascular pathology in youth with HIV.
- Evaluation of advanced imaging modalities for detecting subclinical CVD.
Main Results:
- HIV-associated CVD in youth appears driven by non-atherosclerotic mechanisms like myocardial injury and fibrosis.
- Subclinical myocardial changes, including increased left ventricular mass and reduced strain, are observed via imaging.
- Longitudinal data and multimodal imaging are scarce, especially in African settings.
Conclusions:
- The current understanding of HIV-associated CVD in youth may be incomplete, with atherosclerosis not being the sole driver.
- There is a critical need for longitudinal, mechanistic research, particularly in high-burden regions.
- Developing tailored clinical strategies and policy interventions is essential to reduce long-term cardiovascular morbidity in young PLWH.
Purpose Of Review:
This review synthesises current evidence on the cardiovascular disease (CVD) burden among young people living with HIV. It explores myocardial and vascular pathology, evaluates the role of advanced imaging, and highlights critical gaps in understanding the mechanisms driving HIV-associated CVD in this population.
Recent Findings:
Emerging data suggest that HIV-associated CVD in youth may be predominantly driven by non-atherosclerotic mechanisms, including direct myocardial injury, fibrosis, and remodelling, rather than traditional coronary atherosclerosis. Imaging studies have revealed subclinical myocardial changes such as increased left ventricular mass and reduced strain. Vascular studies show inconsistent findings. However, longitudinal data and multimodal imaging approaches remain scarce, particularly in high-burden regions like Africa. Young adults with HIV face a significant burden of cardiovascular pathology, often subclinical and poorly understood. The prevailing paradigm focused on atherosclerosis may not fully apply to this group, especially in African settings. There is an urgent need for longitudinal, mechanistic research to inform tailored clinical strategies and policy interventions aimed at reducing long-term cardiovascular morbidity in young people with HIV.
Related Concept Videos
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Rheumatic Heart Disease I: Introduction
Coronary Artery Disease IV: Preventive Measures
Rheumatic Heart Disease III: Medical Management
Coronary Artery Disease III: Clinical Manifestations

